Zobrazeno 1 - 10
of 855
pro vyhledávání: '"Friedrich, Asmus"'
Publikováno v:
BMC Ophthalmology, Vol 23, Iss 1, Pp 1-7 (2023)
Abstract Background Post-surgical macular edema (ME) is a common cause of prolonged visual impairment. Here we report on the feasibility and clinical outcomes from the use of a novel suprachoroidal microcatheter to treat post-surgical chronic ME by t
Externí odkaz:
https://doaj.org/article/9368238989e548d8a25756dd63f436d3
Autor:
Jeffrey S. Heier, Allen C. Ho, David S. Boyer, Karl Csaky, Robert Vitti, Lorah Perlee, Karen W. Chu, Friedrich Asmus, Sergio Leal, Oliver Zeitz, Yenchieh Cheng, Thomas Schmelter, David M. Brown
Publikováno v:
Journal of VitreoRetinal Diseases. 7:8-15
Purpose: To compare intravitreal nesvacumab (anti-angiopoietin-2) + aflibercept vs intravitreal aflibercept injection (IAI) in neovascular age-related macular degeneration (nAMD). Methods: Eyes were randomized (1:2:3) to nesvacumab 3 mg + aflibercept
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::1fa5eab6286d91d71da6a9f204e70b4c
https://doi.org/10.1177/24741264221126061
https://doi.org/10.1177/24741264221126061
Autor:
Matzen, Friedrich-Asmus1, Westermann, Benjamin1
Publikováno v:
Die Unternehmensbesteuerung (Ubg). 2020, p269-278. 10p.
Publikováno v:
UbG - Die Unternehmensbesteuerung. 13:269-278
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::d16c8200141a45ed4dc5a3d3fe73c980
https://doi.org/10.9785/ubg-2020-130505
https://doi.org/10.9785/ubg-2020-130505
Autor:
Yury S. Astakhov, VIVID-East investigators, Xiaowei Ren, Gezhi Xu, Young Hee Yoon, You-Xin Chen, Hui Wang, Xiaoxin Li, Friedrich Asmus, Xiaodong Sun
Publikováno v:
Clinical Ophthalmology. 14:741-750
Purpose The prevalence of diabetes and diabetes-related complications, including diabetic macular edema (DME), is increasing in Asia and worldwide. Methods VIVID-East was a 12-month, double-masked, randomized, active-controlled, Phase 3 trial (NCT017
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::110ff63f50b3681f2fc5a2a3739ded38
https://doi.org/10.2147/opth.s235267
https://doi.org/10.2147/opth.s235267
Autor:
Robert Vitti, Friedrich Asmus, Karen W. Chu, Jeffrey S. Heier, Sunil S. Patel, Sergio Leal, David M. Brown, John W. Kitchens, Thomas Schmelter, Lorah Perlee, Charles C. Wykoff, Vladimir Son, Nadia K Waheed
Publikováno v:
Ophthalmology. 127:211-220
Purpose To compare the efficacy and safety of intravitreal aflibercept + anti–platelet-derived growth factor receptor β (PDGFRβ) combination with intravitreal aflibercept injection (IAI) monotherapy in patients with treatment-naive neovascular ag
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::9ab4e751aa3564992c6ad7160cccca32
https://doi.org/10.1016/j.ophtha.2019.09.021
https://doi.org/10.1016/j.ophtha.2019.09.021
Autor:
David M, Brown, David S, Boyer, Karl, Csaky, Robert, Vitti, Lorah, Perlee, Karen W, Chu, Friedrich, Asmus, Sergio, Leal, Oliver, Zeitz, Yenchieh, Cheng, Thomas, Schmelter, Jeffrey S, Heier
Publikováno v:
Retina (Philadelphia, Pa.). 42(6)
The purpose of this study was to compare intravitreal nesvacumab (anti-angiopoietin 2) plus aflibercept with intravitreal aflibercept injection (IAI) in diabetic macular edema.The eyes (n = 302) were randomized (1:2:3) to nesvacumab 3 mg + aflibercep
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=pmid________::bd71ec827669abd6378e3f4f4d14cd33
https://pubmed.ncbi.nlm.nih.gov/35234673
https://pubmed.ncbi.nlm.nih.gov/35234673
Autor:
David M. Brown, Christiane Ahlers, Jean-François Korobelnik, Francesco Boscia, Paul Mitchell, Brigitte Stemper, Jeffrey S. Heier, Robert Vitti, Kay D. Rittenhouse, Frank G. Holz, Friedrich Asmus, Namrata Saroj, Nicolas Feltgen, Yuichiro Ogura
Publikováno v:
Ophthalmology Retina
Ophthalmology Retina, Elsevier, 2019, 3 (7), pp.553-560. ⟨10.1016/j.oret.2019.02.010⟩
Ophthalmology Retina, Elsevier, 2019, 3 (7), pp.553-560. ⟨10.1016/j.oret.2019.02.010⟩
International audience; PURPOSE: To evaluate the impact of baseline retinal capillary nonperfusion (RNP) and macular retinal capillary nonperfusion (MNP) status on outcomes at week 24 (W24). DESIGN: Post hoc analyses of 2 phase 3, randomized, double-
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::9e1a60cf094ff711584d47e6b9d31bab
https://doi.org/10.1016/j.oret.2019.02.010
https://doi.org/10.1016/j.oret.2019.02.010
Autor:
Stephen R. Russell, Arlene V. Drack, Artur V. Cideciyan, Samuel G. Jacobson, Bart P. Leroy, Caroline Van Cauwenbergh, Allen C. Ho, Alina V. Dumitrescu, Ian C. Han, Mitchell Martin, Wanda L. Pfeifer, Elliott H. Sohn, Jean Walshire, Alexandra V. Garafalo, Arun K. Krishnan, Christian A. Powers, Alexander Sumaroka, Alejandro J. Roman, Eva Vanhonsebrouck, Eltanara Jones, Fanny Nerinckx, Julie De Zaeytijd, Rob W. J. Collin, Carel Hoyng, Peter Adamson, Michael E. Cheetham, Michael R. Schwartz, Wilhelmina den Hollander, Friedrich Asmus, Gerard Platenburg, David Rodman, Aniz Girach
Publikováno v:
Nature Medicine, 28, 1014-1021
NATURE MEDICINE
Nature Medicine, 28, 5, pp. 1014-1021
NATURE MEDICINE
Nature Medicine, 28, 5, pp. 1014-1021
CEP290-associated Leber congenital amaurosis type 10 (LCA10) is a retinal disease resulting in childhood blindness. Sepofarsen is an RNA antisense oligonucleotide targeting the c.2991+1655A>G variant in the CEP290 gene to treat LCA10. In this open-la
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::547b93068a0384a77df09d77369a5f9a
https://pubmed.ncbi.nlm.nih.gov/35379979
https://pubmed.ncbi.nlm.nih.gov/35379979
Publikováno v:
Zeitschrift für Bankrecht und Bankwirtschaft. 30:197-208
Zusammenfassung Anlässlich des bevorstehenden Brexits und einer Reihe aktueller Rechtsänderungen verschafft der vorliegende Beitrag dem Leser einen Überblick über die Möglichkeiten von Wertpapierdienstleitungsunternehmen aus Drittstaaten („Dri
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::758ad23b75d23cd85332f7a6a6aba9a3
https://doi.org/10.15375/zbb-2018-0403
https://doi.org/10.15375/zbb-2018-0403